"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
| Descriptor ID |
D013759
|
| MeSH Number(s) |
D02.455.849.090.810
|
| Concept/Terms |
Dronabinol- Dronabinol
- delta(9)-THC
- 9-ene-Tetrahydrocannabinol
- 9 ene Tetrahydrocannabinol
- THC
- delta(1)-Tetrahydrocannabinol
- delta(1)-THC
- delta(9)-Tetrahydrocannabinol
- Tetrahydrocannabinol
|
Below are MeSH descriptors whose meaning is more general than "Dronabinol".
Below are MeSH descriptors whose meaning is more specific than "Dronabinol".
This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 6 | 4 | 10 |
| 2018 | 3 | 1 | 4 |
| 2019 | 3 | 5 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Dronabinol" by people in Profiles.
-
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19. Int J Mol Sci. 2021 Feb 17; 22(4).
-
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS study. Pharm Stat. 2021 05; 20(3):675-691.
-
Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19? Curr Pharm Des. 2021; 27(13):1564-1578.
-
Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches. Int J Biol Macromol. 2021 Jan 31; 168:474-485.
-
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland. Drug Test Anal. 2021 Apr; 13(4):867-870.
-
E-cigarette or Vaping Product Use-Associated Lung Injury Produced in an Animal Model From Electronic Cigarette Vapor Exposure Without Tetrahydrocannabinol or Vitamin E Oil. J Am Heart Assoc. 2020 09 15; 9(18):e017368.
-
?9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Int J Mol Sci. 2020 Aug 28; 21(17).
-
Diagnosing EVALI in the Time of COVID-19. Chest. 2020 11; 158(5):2034-2037.
-
E-cigarette Use, or Vaping, Practices and Characteristics Among Persons with Associated Lung Injury - Utah, April-October 2019. MMWR Morb Mortal Wkly Rep. 2019 Oct 25; 68(42):953-956.
-
E-cigarette Product Use, or Vaping, Among Persons with Associated Lung Injury - Illinois and Wisconsin, April-September 2019. MMWR Morb Mortal Wkly Rep. 2019 Oct 04; 68(39):865-869.